AVB 401
Alternative Names: AVB-401; AVB-401 BAG3 DCMLatest Information Update: 14 Apr 2023
At a glance
- Originator AavantiBio
- Developer Solid Biosciences
- Class Cardiovascular therapies; Gene therapies
- Mechanism of Action BAG3 protein replacements; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Dilated cardiomyopathy